JNJ

2025Q2BMO

Johnson & Johnson primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2025-07-16 · Fiscal end 2025-06-30 · Features as of 2025-07-15

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS2.68
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move1.8%
IV front—
P/C full—
P/C front—
Features as of2025-07-15

Run-up

Close—
Ret 5d-0.4%
Ret 10d+1.6%
Ret 20d-1.2%
Ret 30d-0.0%

Post-Earnings Data

Results & reaction

Print

Actual EPS
2.77Beat
Estimated EPS2.68
Actual revenue
23.7B
Surprise %+3.4%
Beat / missBeat
Beat streak 44
Beat streak 88

Reaction

1-day stock reaction+2.8%
Implied vs actual

Implied 1.8%Actual 3.3%

Gap reaction+3.3%
Day result+6.2%
Next-day upYes
Realized / IV1.82×

Post tape

Post 5d+2.6%
Post 10d+1.5%
Post volume22.1M
Vol ×10d3.14×
Vol ×20d2.68×
Post range3.9%